Chloroquine Phosphate Suppliers & Bulk Manufacturers

Available Forms: Tablets / injection

Available Strengths: 100 mg , 150 mg , 200 mg , 250 mg , 40 mg/ml

Reference Brands: Aralen (USA), Nivaquine (EU), Lariago (India)

Category: Anthelmintic

Chloroquine Phosphate is a Anthelmintic product available as Tablets / injection in strengths 100 mg , 150 mg , 200 mg , 250 mg , 40 mg/ml. It corresponds to the reference brands Aralen (USA), Nivaquine (EU), Lariago (India). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Chloroquine is an antiparasitic medicine primarily used for the treatment and prevention of malaria caused by certain species of Plasmodium parasites that are sensitive to chloroquine therapy. The medicine works by interfering with the growth and survival of the malaria parasite inside red blood cells. It increases the concentration of heme within the parasite, which is toxic to the organism, leading to the destruction of the parasite and helping stop the infection from spreading further in the body. Because of this mechanism, chloroquine has been widely used for decades in regions where chloroquine-sensitive malaria is still present.

In addition to malaria treatment, chloroquine is also used in some cases to treat extraintestinal amebiasis, a parasitic infection that affects organs such as the liver. Beyond its antiparasitic activity, chloroquine has immunomodulatory effects, which means it can influence the immune system. Due to these properties, it has been used in certain autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematosus when prescribed and monitored by healthcare professionals.

Chloroquine is usually administered orally in tablet form, although injectable forms may also be available in some medical settings. The dosage and duration of treatment depend on the condition being treated, the severity of the infection, and regional treatment guidelines, especially because some malaria parasites have developed resistance to chloroquine. In areas where resistant strains are common, alternative or combination antimalarial medicines are typically recommended.

The medicine has been used for many years and has an established safety profile when taken as directed. It has also been considered relatively safe for use during pregnancy in situations where malaria treatment is necessary, though medical supervision is always required. Like any medication, chloroquine may cause side effects in some individuals, which can include gastrointestinal discomfort, headache, or mild visual disturbances in certain cases.